A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
This research study, called ATTAIN-Hypertension, is investigating a new medication, orforglipron, for adults who have high blood pressure and are also overweight or living with obesity. The main goal is to find out if orforglipron is effective in lowering blood pressure and to check how safe it is for people to use. Participants will be randomly assigned to either receive the new medicine or a 'dummy' pill (placebo) that looks the same but contains no active drug. This is a common way to test new treatments, helping researchers understand the medicine's true effects. It's part of a larger research programme looking into orforglipron.
En un coup d'œil
De quoi parle cette étude ?
This study, known as ATTAIN-Hypertension, is a clinical trial focused on a new medicine called orforglipron (which has a code name LY3502970). The main purpose of this research is to see if orforglipron can help people who have high blood pressure, especially if they are also overweight or living with obesity. High blood pressure can lead to serious health problems like heart attacks and strokes, so finding effective treatments is very important.
Researchers want to understand two key things: first, if orforglipron actually works to lower blood pressure in this group of people (this is called its 'efficacy'), and second, whether it is safe to use and what side effects it might have (this is called its 'safety'). To do this, some people in the study will receive orforglipron, while others will receive a 'placebo', which looks identical but doesn't contain any active medicine. This allows doctors to compare the results and see if the new medicine is having a real effect.
This specific study is part of a bigger research effort investigating orforglipron. By participating, you would be helping medical science learn more about how to treat high blood pressure in people who also struggle with their weight, potentially leading to new treatment options in the future.
Points clés
- The study is testing a new medicine, orforglipron, for high blood pressure.
- It's for adults who also have obesity or are overweight.
- The goal is to check how well the medicine works and if it's safe.
- Some participants will get the actual medicine, others a dummy pill.
- Participation involves regular clinic visits and health checks.
- You can leave the study at any time if you change your mind.
Qui peut être éligible ?
To be considered for this study, you must be 18 years old or older. The study is open to both men and women.
Since this study is part of a larger research programme, there are specific guidelines that decide who can and cannot take part. These guidelines are carefully considered to make sure the study is safe for everyone involved and that the results are clear.
If you are interested, a member of the research team will explain these guidelines in detail and check if you meet all the necessary requirements for screening. They will ask questions about your health and medical history.
Cet étude pourrait-elle vous convenir ?
Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.
- Avez-vous 18 ans ou plus ?
- Do you have high blood pressure?
- Are you currently overweight or living with obesity?
- Êtes-vous en mesure d'assister à des rendez-vous réguliers à la clinique ?
En quoi consiste la participation ?
Taking part in this study would involve a series of visits to the clinic over a period of time. During these visits, you would have various health checks, such as measurements of your blood pressure, weight, and blood tests. You would be given either the study medicine (orforglipron) or a dummy pill (placebo) to take regularly, as instructed by the study team.
The specific number of visits and the total length of your participation would be explained fully by the study team during your initial conversations. There will also be follow-up appointments to monitor your health and how you are responding to the medication. All procedures, including medication doses and the duration of the study, will be carefully set out in the study plan.
Risques et avantages potentiels
Locations (99)
- Elite Clinical Studies, LLCCode postal vérifiéPhoenix, États-Unis
- Valley Clinical Trials, Inc.Code postal vérifiéCovina, United States
- Valley Clinical Trials, Inc.Code postal vérifiéNorthridge, United States
- Chase Medical Research, LLCCode postal vérifiéWaterbury, United States
- Excel Medical Clinical TrialsCode postal vérifiéBoca Raton, United States
- Care Access - BrandonCode postal vérifiéBrandon, United States
- Northeast Research Institute - Downtown OfficeCode postal vérifiéJacksonville, États-Unis
- Peace River Cardiovascular CenterCode postal vérifiéPort Charlotte, United States
- East-West Medical Research InstituteCode postal vérifiéHonolulu, United States
- Sinai Hospital Of BaltimoreCode postal vérifiéBaltimore, États-Unis
- Ascension Saint Agnes Heart CareCode postal vérifiéBaltimore, États-Unis
- Lucida Clinical TrialsCode postal vérifiéNew Bedford, United States
Questions fréquentes
Qu'est-ce que l'hypertension artérielle ?
High blood pressure, or hypertension, means your blood is pushing too hard against the walls of your arteries. Over time, this can damage your blood vessels and lead to serious health problems like heart disease or stroke.
What is 'obesity or overweight' in this study?
This refers to having a body weight that is higher than what is considered healthy for your height. The study will use specific measurements, like Body Mass Index (BMI), to determine this.
Qu'est-ce qu'un 'placebo' ?
A placebo is a 'dummy' pill or treatment that looks exactly like the real medicine but contains no active drug. It helps researchers see if the real medicine is actually working or if improvements are due to other factors.
Saurai-je si je reçois le vrai médicament ou le placebo ?
No, neither you nor the study team will know whether you are receiving the active medicine or the placebo. This is to ensure the study results are fair and unbiased. This is called 'blinding'.
Puis-je arrêter de participer à l'étude si je le souhaite ?
Yes, absolutely. Your participation is completely voluntary, and you can choose to leave the study at any time, for any reason, without it affecting your future medical care.
Comment en savoir plus
Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.
Discussion
Discussion communautaire
Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.